Literature DB >> 16076328

Measuring men's opinions of prostate needle biopsy.

Jessica C C Medd1, Martin R Stockler, Ruth Collins, Andre Lalak.   

Abstract

BACKGROUND: Needle biopsy of the prostate is an important, common, invasive procedure. Little is known about men's perceptions of it. The present study was designed to assess men's experience of prostate biopsy, to determine the feasibility of a randomized trial of interventions to alleviate distress during prostate biopsy, and to develop a pragmatic outcome measure for such a trial.
METHODS: Of 33 consecutive men undergoing prostate biopsy at a Sydney (Australia), tertiary referral urology centre 31 men were selected for study. A cross-sectional, observational was performed. Participants completed both a 24-item questionnaire assessing relevant symptoms, attitudes and emotional responses and a semistructured interview shortly after their prostate biopsy. Each item of the questionnaire was rated on an 11-point scale from 0 (no trouble at all), to 10 (worst they could imagine).
RESULTS: The mean score for discomfort was 4.4 with 32% scoring > or =7; the mean score for pain was 4.2 with 29% scoring > or =7. The other most troubling aspects were: 'waiting for the result' (mean 4.4, 32% > or =7) and 'fear of the result' (mean 3.7, 32% > or =7). Seventy-one per cent of subjects stated that they would have been willing to participate in a randomized trial of interventions to make prostate biopsies less unpleasant. Thirteen of the 24 items were retained and refined for use as an outcome measure for subsequent trials.
CONCLUSIONS: Many men experience pain, discomfort and anxiety during prostate needle biopsy and most would be willing to participate in trials of interventions to make it less unpleasant.

Entities:  

Mesh:

Year:  2005        PMID: 16076328     DOI: 10.1111/j.1445-2197.2005.03477.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  7 in total

Review 1.  Placing prostate cancer disparities within a psychosocial context: challenges and opportunities for future research.

Authors:  Adolfo G Cuevas; Claudia Trudel-Fitzgerald; Leslie Cofie; Masayoshi Zaitsu; Jennifer Allen; David R Williams
Journal:  Cancer Causes Control       Date:  2019-03-22       Impact factor: 2.506

2.  Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations.

Authors:  Aaron P Brown; David S Wendler; Kevin A Camphausen; Franklin G Miller; Deborah Citrin
Journal:  J Clin Oncol       Date:  2008-08-20       Impact factor: 44.544

3.  Quality Assessment and Comparison of Plasma-Derived Extracellular Vesicles Separated by Three Commercial Kits for Prostate Cancer Diagnosis.

Authors:  Bairen Pang; Ying Zhu; Jie Ni; Juanfang Ruan; James Thompson; David Malouf; Joseph Bucci; Peter Graham; Yong Li
Journal:  Int J Nanomedicine       Date:  2020-12-15

4.  Prospective analysis of pain expectancy and experience during MR-fusion prostate biopsy: does reality match patients' expectancy?

Authors:  Philipp Krausewitz; Helene Schmeller; Julian Luetkens; Darius Dabir; Jörg Ellinger; Manuel Ritter; Rupert Conrad
Journal:  World J Urol       Date:  2022-07-14       Impact factor: 3.661

5.  What predicts emotional response in men awaiting prostate biopsy?

Authors:  AnnMarie Groarke; Ruth Curtis; Deirdre M J Walsh; Francis J Sullivan
Journal:  BMC Urol       Date:  2018-04-24       Impact factor: 2.264

Review 6.  Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis.

Authors:  Bairen Pang; Ying Zhu; Jie Ni; James Thompson; David Malouf; Joseph Bucci; Peter Graham; Yong Li
Journal:  Theranostics       Date:  2020-01-16       Impact factor: 11.556

7.  'Pain-free TRUS B': a phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasonography-guided prostate biopsy (ANZUP 1501).

Authors:  Dickon Hayne; Jeremy Grummet; David Espinoza; Steve P McCombie; Venu Chalasani; Kate S Ford; Mark Frydenberg; Peter Gilling; Barbara Gordon; Cynthia Hawks; Alex Konstantatos; Andrew J Martin; Anthony Nixon; Colin O'Brien; Manish I Patel; Shomik Sengupta; Shekib Shahbaz; Shalini Subramaniam; Scott Williams; Henry H Woo; Martin R Stockler; Ian D Davis; Nick Buchan
Journal:  BJU Int       Date:  2021-07-30       Impact factor: 5.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.